Abstract
Three hypogammaglobulinaemic patients with non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy were treated with lymphoblastoid alpha-interferon. All showed a striking improvement in serum aminotransferases after the start of each course of treatment.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Agammaglobulinemia / therapy
-
Chronic Disease
-
Drug Contamination*
-
Fluid Therapy
-
Hepatitis C / therapy*
-
Hepatitis C / transmission
-
Hepatitis, Viral, Human / therapy*
-
Humans
-
Interferon Type I / therapeutic use*
-
Plasma / microbiology
-
Splenomegaly / therapy
-
Time Factors
-
Transaminases / blood
-
gamma-Globulins / adverse effects*
Substances
-
Interferon Type I
-
gamma-Globulins
-
Transaminases